- ►annals.org [PDF] PP Glasziou, L Irwig, S Heritier, RJ Simes, A … - Annals of Internal Medicine, 2008 - Am Coll Physicians Objective: To estimate, in patients receiving cholesterol-lowering medication,
the variation in initial response to treatment, the long- term drift from
initial response, and the detectability of long-term changes in ... Cited by 7 - Related articles - All 5 versions
MJ McLaughlin - The American Journal of Medicine, 2007 - Elsevier Heterogeneity of treatment effects (HTE) is a phenomenon wherein the same
treatment produces different responses in different patients. Following
scientific presentations at a conference on HTE in drug therapy, a ... Cited by 4 - Related articles - All 3 versions
[CITATION] Monitoring Cholesterol Levels: Measurement Error or True Change?
C Activities, N Medicines, NPCT Network - MeReC Bulletin, 2009 - npc.co.uk ICSs are safe and effective for most patients with asthma, although the risk of
systemic side effects is greater when higher doses are used. The dose of ICS
should be titrated to the lowest dose at which effective control of asthma ... Related articles - Cached - All 2 versions
Y Ben-Haim, M Zacksenhouse, C Keren, CC … - Medical Hypotheses, 2009 - Elsevier The diagnosis of diabetes, based on measured fasting plasma glucose level,
depends on choosing a threshold level for which the probability of failing to
detect disease (missed diagnosis), as well as the probability of falsely ... Related articles - All 49 versions
MH Criqui, BA Golomb - The Lancet, 2008 - Elsevier Drug treatment for dyslipidaemia is a mainstay of clinical practice in developed
countries. Monitoring of lipid-lowering treatment contributes additionally to
the already substantial cost. 1 In the randomised LIPID trial (pravastatin ... Related articles - All 35 versions
Y Ben-Haim, M Zacksenhouse, C Keren, CC … - technion.ac.il Diagnosis and treatment is a complex interaction of subjective information and
impressions, objective data, individual needs and preferences, and resource
constraints. The interpretation of quantitative information relies on ... Related articles - View as HTML - All 5 versions
[CITATION] Last literature review for version 16.3: Wed Oct 01 00: 00: 00 GMT 2008| This topic last …
C Hogan - Accessed at www. clinical-labs. org/documents/ …, 2008 - clinical-labs.org The Centers for Medicare and Medicaid Services (CMS) and the Medicare Payment
Advisory Commission (MedPAC) have both cited increased use of testing as a
factor contributing to spending growth. CMS defines testing to include a ... Cited by 2 - Related articles - View as HTML - All 2 versions